| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000002203 |
| Receipt No. | R000002707 |
| Official scientific title of the study | Study on the efficacy of ultrasound-guided nerve blockade |
| Date of disclosure of the study information | 2009/07/15 |
| Last modified on | 2016/06/10 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Study on the efficacy of ultrasound-guided nerve blockade | |
| Title of the study (Brief title) | Study on the efficacy of ultrasound-guided nerve blockade | |
| Region |
|
|
| Condition | |||||||
| Condition | Patients undergoing surgery under nerve blocks | ||||||
| Classification by specialty |
|
||||||
| Classification by malignancy | Others | ||||||
| Genomic information | NO | ||||||
| Objectives | |
| Narrative objectives1 | To investigate the effecacy and adverse effects of ultrasound-guided regional anesthesia using patients undergoing surgery |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Sensory and motor blockade, success rate, onset time, duration, side effects |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Each approach of the brachial plexus block | |
| Interventions/Control_2 | thoracic paravertebral block | |
| Interventions/Control_3 | Ultrasound-guided regional anesthesia | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients (ASA I – II) undergoing surgery for which regional anesthesia is recommended | |||
| Key exclusion criteria | Patients with a history of diabetes mellitus, neurologic disease, or infections at the site of injection | |||
| Target sample size | 2100 | |||
| Research contact person | |
| Name of lead principal investigator | Shinichi Sakura |
| Organization | Shimane University School of Medicine, University Hospital |
| Division name | Surgical Center |
| Address | 89-1, Enya-cho, Izumo City |
| TEL | 81-853-20-2295 |
| ssakura@med.shimane-u.ac.jp | |
| Public contact | |
| Name of contact person | Shinichi Sakura |
| Organization | Shimane University School of Medicine, University Hospital |
| Division name | Surgical Center |
| Address | 89-1, Enya-cho, Izumo City |
| TEL | 81-853-20-2295 |
| Homepage URL | |
| ssakura@med.shimane-u.ac.jp | |
| Sponsor | |
| Institute | Surgical Center & Department of Anesthesiology, Shimane University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | University Hospital, Shimane University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002707 |